Cargando…

Dupilumab in acquired perforating dermatosis: A potential new treatment

Detalles Bibliográficos
Autores principales:	Alsebayel, Musaed M., Alzaid, Tariq, Alobaida, Saud A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463549/ https://www.ncbi.nlm.nih.gov/pubmed/36097624 http://dx.doi.org/10.1016/j.jdcr.2022.08.013

Ejemplares similares

Acquired perforating dermatosis in patients with copper deficiency
por: Varghese, Jeffrey Alex, et al.
Publicado: (2021)

Acquired perforating dermatosis in the setting of hepatocellular carcinoma
por: Filho, Reinaldo Tovo, et al.
Publicado: (2021)

Treatment of acquired perforating dermatosis with colchicine
por: Kharghoria, Geetali, et al.
Publicado: (2022)

Acquired perforating dermatosis in a patient with chronic renal failure
por: Fernandes, Karen de Almeida Pinto, et al.
Publicado: (2016)

Successful Treatment of Acquired Perforating Dermatosis with Colchicine
por: Gil, Francisco, et al.
Publicado: (2021)

Giant variant of acquired perforating dermatosis in a renal dialysis patient
por: Metterle, Lauren, et al.
Publicado: (2017)

Treatment of a perforating dermatosis with apremilast
por: McMichael, Josette, et al.
Publicado: (2021)

Acquired perforating dermatosis with associated complicated cellulitis and amputation in a hemodialysis patient
por: Domingos, Ana, et al.
Publicado: (2021)

Acquired perforating dermatosis in patients on peritoneal dialysis: a report of 3 cases
por: Viejo-Boyano, Iris, et al.
Publicado: (2023)

Successful treatment of linear immunoglobulin A bullous dermatosis with dupilumab in a pediatric patient
por: Almuhanna, Nouf, et al.
Publicado: (2023)

Acquired Perforating Dermatosis in a Patient on Peritoneal Dialysis: A Case Report and Review of the Literature
por: Imam, Talha H., et al.
Publicado: (2018)

Acquired perforating dermatosis in a diabetic patient on hemodialysis
por: Hemachandar, R.
Publicado: (2016)

Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia
por: Jin, Annie, et al.
Publicado: (2019)

Can’t handle the itch? Refractory immunotherapy-related transient acantholytic dermatosis: prompt resolution with dupilumab
por: Shelton, Eva, et al.
Publicado: (2022)

Acquired perforating dermatosis and Addison’s disease due to disseminated histoplasmosis: Presentation and clinical outcomes
por: Choudhary, Nidhi, et al.
Publicado: (2013)

Perforating Dermatosis in a Patient Receiving Azathioprine
por: Grillo, Emiliano, et al.
Publicado: (2013)

Dermoscopy Features of Acquired Perforating Dermatosis Among 39 Patients
por: Wang, Wenju, et al.
Publicado: (2021)

Acquired Perforating Dermatosis in Patients with Chronic Renal Failure and Diabetes Mellitus
por: Hong, Seok-Beom, et al.
Publicado: (2004)

A Clinicopathologic Study of Thirty Cases of Acquired Perforating Dermatosis in Korea
por: Kim, Seo Wan, et al.
Publicado: (2014)

Clinical characteristics and prognosis of acquired perforating dermatosis: A case report
por: Wang, Mei-Fang, et al.
Publicado: (2020)

Pruritic Periumbilical Plaque as a Presentation of a Rare Perforating Dermatosis
por: Bathina, Meghana, et al.
Publicado: (2020)

Acquired Perforating Dermatosis as a Paraneoplastic Feature: A Case Report, Literature Review, and Novel Association
por: Imran, Nashat
Publicado: (2023)

Dupilumab may be an alternative option in the treatment of acquired reactive perforating collagenosis combined with AD
por: Ying, Yang, et al.
Publicado: (2021)

The SLC29A3 variant, neutrophilic dermatosis, and hyperferritinemia imitate systemic juvenile idiopathic arthritis in a Saudi child: a case report
por: Alansari, Shahad, et al.
Publicado: (2023)

Predictors of Acquired Perforating Dermatosis in Uremic Patients on Hemodialysis: A Case-Control Study
por: Weng, Cheng-Hao, et al.
Publicado: (2012)

Dupilumab improve acquired reactive perforating collagenosis characterized by type 2 inflammation
por: Liu, Ben, et al.
Publicado: (2023)

Dermatosis neglecta
por: Sasaya, Elisa Mayumi Kubo, et al.
Publicado: (2015)

Acquired perforating dermatosis: A clinicopathologic study, and the features of dermoscopy and reflective confocal microscopy of 37 cases
por: Gao, Zhe, et al.
Publicado: (2023)

Linear IGA bullous dermatosis potentially triggered by vaccination
por: Corrà, Alberto, et al.
Publicado: (2022)

Allopurinol in the treatment of acquired reactive perforating collagenosis()
por: Tilz, Hemma, et al.
Publicado: (2013)

Treatment of transient acantholytic dermatosis with liquid nitrogen
por: Galamgam, Jayden, et al.
Publicado: (2020)

UNUSUAL CLINICOPATHOLOGICAL AND IMMUNOLOGICAL PRESENTATION OF CHRONIC BULLOUS DERMATOSIS OF CHILDHOOD (LINEAR IGA DERMATOSIS)
por: Fahad, Al-Saif, et al.
Publicado: (2011)

Successful treatment of acquired reactive perforating collagenosis with itraconazole
por: Ye, Binrong, et al.
Publicado: (2021)

Hypereosinophilic Dermatitis: Successful Treatment with Dupilumab
por: Wu, Chenyu, et al.
Publicado: (2023)

Successful Treatment of Severe Subcorneal Pustular Dermatosis with Adalimumab
por: Chen, Jiaoquan, et al.
Publicado: (2022)

Neutrophilic dermatosis of dorsal hands
por: Kaur, S., et al.
Publicado: (2015)

Reactive perforating collagenosis successfully treated with dupilumab
por: Gil‐Lianes, Javier, et al.
Publicado: (2022)

Treatment of lichen sclerosus and hypertrophic scars with dupilumab
por: Peterson, Danielle M., et al.
Publicado: (2022)

Angioimmunoblastic T-cell lymphoma unmasked by treatment with dupilumab
por: Choo, Zi-Yi, et al.
Publicado: (2023)

Dupilumab-Induced Pancreatitis
por: Jasti, Vivek V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ep50u16pdait775asm6i2olkd3